Teikoku Pharma USAOrganisationDevelopsDexmedetomidineclinicaltrials.govTrialsDexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypePhase 2, Recruiting, 2025, 150 people, 25 Sept 2023, clinicaltrials.gov